Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Edan

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
A quality network model for the daily care of multiple sclerosisL D Blumhardt, B J Vermeij, M Amato, et al.
Neurology|May 20, 1999
Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics GroupD Brassat, C Azais-Vuillemin, J Yaouanq, et al.
Genes and Immunity|October 11, 2003
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosisI Cournu-Rebeix, E Génin, G Lesca, et al.
Lancet (London, England)|May 30, 2001
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyG Comi, M Filippi, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.
Journal of Neurology|April 12, 2006
Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?D Drapier, S Drapier, P Sauleau, et al.
Journal of Neuroimmunology|May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine responseJ Kovalchin, J Krieger, M Genova, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
A quality network model for the daily care of multiple sclerosisL D Blumhardt, B J Vermeij, M Amato, et al.
Neurology|May 20, 1999
Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics GroupD Brassat, C Azais-Vuillemin, J Yaouanq, et al.
Genes and Immunity|October 11, 2003
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosisI Cournu-Rebeix, E Génin, G Lesca, et al.
Lancet (London, England)|May 30, 2001
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyG Comi, M Filippi, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosisR G Ghalie, E Mauch, G Edan, et al.
Journal of Neurology|April 12, 2006
Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?D Drapier, S Drapier, P Sauleau, et al.
Journal of Neuroimmunology|May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine responseJ Kovalchin, J Krieger, M Genova, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Pageof 13